United States · FDA National Drug Code directory
Eohilia
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64764-105_6b8f012a-d7af-4200-a5b8-5a56f6962ccd
- Product NDC
- 64764-105
- Form
- SUSPENSION
- Composition / generic term
- Budesonide
- Labeler
- TAKEDA PHARMACEUTICALS AMERICA, INC.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240209
- Source listing expiry
- 20261231
Source-listed ingredients
- BUDESONIDE — 2 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 POUCH in 1 CARTON (64764-105-00) / 10 mL in 1 POUCH (64764-105-01) · 64764-105-00
- 60 POUCH in 1 CARTON (64764-105-60) / 10 mL in 1 POUCH (64764-105-10) · 64764-105-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →